France Innovation Scientifique & Transfert Publishes a New Report on the HIV Therapy Patent Landscape. This Report Shows a Drastic Need for Fundamental Research.
|
|
|
| Posted
:
Tue, 03 Nov 2009 16:04:02 GMT |
| Author
:
FIST SA
|
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
| Press Release
News |
Home
|
|
|
|
PARIS - (Business Wire) “IP Overview HIV Therapy 2009” ( www.frinnov.fr/en/ip-overview/sciences-de-la-vie/hiv-therapy-2.html ) establishes a panorama of the patents claiming “HIV and AIDS treatments” and analyses the key and emerging thematic and the strategic positions of the actors involved in this sector. In order to fully analyze this field, the information coming from 6800 published patents and patent applications was aggregated. Highlights of this report This analysis shows a decorrelation between major patent owners and market leaders. Companies having the largest patent portfolio claiming HIV treatments, Pfizer and Merck (350 patents fillings, each) do not belong to the HIV market leaders while Gilead with only 44 patent filings has the best market results. This position is therefore not a result of internal research but is based on the acquisition of key molecules such as emtricitabine coming from a collaboration between IOCB and Leuven Katholic University and tenofovir from Emory University. In addition, according to Sylvain Goiran, IP Overview principal analyst: ”Despite the huge increase in HIV market and the needs for new therapies, multiple signals are showing that HIV R&D is running short of new thematic and is practically collapsing since 2005 with a 40% drop in the number of patent applications”. Fewer filings means fewer new molecules entering clinical trials and thus fewer chances for new drugs on the market in the future. There is undoubtedly a need to get back to basic research. It is therefore a unique opportunity for academic research to play a crucial role in this field in the coming years. Indeed, like Gilead, pharmaceutical companies could adapt their strategies and go for “open innovation” by buying or licensing active molecules from academic laboratories or other companies. So, a deep knowledge of the patent portfolio of HIV therapy can help companies to identify players that patented molecules acting on new therapeutic targets. Key reasons to purchase this report: This report provides a comprehensive analysis of why the R&D of HIV treatments is at a crossroads, as can be seen on the patent perspective. It gives detailed information about some of the key aspects of the pharmaceutical industry and helps clients to identify the driving forces and current trends in this field. “This represents a fully new approach which is complementary with classical market studies.” concludes Sylvain Goiran. For more information visit www.frinnov.fr/en/ip-overview/sciences-de-la-vie/hiv-therapy-2.html Key items - Outline of the market and the pipeline
- Protection strategies:
- Evolution of patent filings
- Priority patent applications
- Extensions
- Analysis of industrial patents over time
- Study of the granting of US and European patents
- Topology of patents in the sector
- Breakdown of patents into therapeutic targets, applications, class of compounds and cross-analyses
- Keys applicants and key inventors
- Key and emerging thematic
- Conclusion
Sylvain Goiran IP Overview Principal Analyst sylvain.goiran@fist.fr +33 (0)140 510 090
|

Copyright © 2008
Business Wire. All rights reserved.
|
|
|
|
|
Related
News
Win a Ski Holiday with 1Stop Travel Insurance BASILDON, England -
With the news that ski tour operators are reducing bed numbers in
anticipation of a second slow year due to recession and a weak pound,
the outlook for skiers on a budget is looking decidedly bleak this
season, unless you book early.
To combat this
Research and Markets: Business Process Outsourcing Report - Comprehensive Profile of 462 Companies Operating in the UK Market DUBLIN -
Research and Markets (
TDNet Provides Library Search, Discovery E-resource Management Software
TDNet Inc., a leading provider of e-resource search, access and management software for libraries and information centers, recently announced a new "discovery to delivery" platform for corporate libraries and information centers./I/P
PWest Chester, PA (PRWEB) November 13, 2009...
America's First On-The-Go Aromatherapy Product, PocketAroma(R), Retains Transmedia Group To Exude That Sweet Smell of Publicity
BOCA RATON, Fla., Nov. 23 /PRNewswire/ -- Relaxation is in the air and the source of it, PocketAroma® (www.PocketAroma.com), has tapped TransMedia Group to see that publicity wafts along with it. The new, palm-sized aromatherapy dispenser ple...
TransMedia Group Hired to Debunk Blockbuster Film 2012
BOCA RATON, Fla., Nov. 23 /PRNewswire/ -- While the hit film 2012 chills and horrifies filmgoers worldwide, its apocalyptic premise is completely false, according to author Bob Waxman in his new book 2012: The Ultimate Meaning, to be published by Parag...
DEMDACO Partners With SHS for Willow Tree(R) Online Efforts
KANSAS CITY, Mo., Nov. 23 /PRNewswire/ -- DEMDACO has chosen Sullivan Higdon & Sink (SHS) to help build a larger online presence for its Willow Tree(®) brand. Based in Leawood, Kan., DEMDACO will launch a new Willow Tree Web site for this holiday season.
"We...
Maintenance Becomes the Focus for Agricultural Chemical Plants in 2010, an Industrial Info News Alert SUGAR LAND, TX -- 11/23/09 --
Researched by Industrial Info Resources
(Sugar Land, Texas) -- Producers of fertilizers, herbicides, pesticides and
related products make up a rather small segment of the
|
|
|
|
|
|
|
|
|